Practitioner Diversion Awareness Conference
March 18-19, 2019; Renaissance Cleveland Hotel – Cleveland, Ohio
The Drug Enforcement Administration (DEA) held a Practitioner Diversion Awareness Conference (PDAC) on March 18 & 19, 2019 in Cleveland, Ohio. This was a one-day conference, repeated on the second day, for the convenience of the practitioner community. The conference was developed and designed to address the growing problem of diversion of pharmaceutical controlled substances throughout the United States. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The objective of this conference was to educate healthcare professionals on ways to address and respond to potential diversion activity.
Over 286, veterinarians, dentists, physician assistants, and nurse practitioners. The conference attendees received approximately seven hours of instruction on a variety of topics. The presentations included; The Opioid Epidemic and the Practice of Legitimate Medicine, Drugs of Abuse and Trends, Prescription Drug Monitoring Programs, Prescriptions for Controlled Substances, Methods of Diversion and Effective Controls for Controlled Substances, State Medical Board, Inventories, Records, and Reports, Registration Issues, Disposal, Return of Patient Meds, and Options for Patients, Telemedicine, Training & Resources and Probation/Physician Wellness.
Selected presentations from the Cleveland, Ohio PDAC are below.
Drugs of Abuse and Trends – Antonio Guzman, Associate Section Chief, Diversion Control Division, DEA
Opioid Prescribing Regulation – A.J. Groeber, Executive Director, State Medical Board of Ohio
Prescriptions for Controlled Substances – Loren T. Miller, Section Chief, Policy Section, Diversion Control Division, DEA
Methods of Diversion and Effective Controls for Controlled Substances – Scott A. Brinks, Staff Coordinator, Import/Export and Chemical Section, Diversion Control Division, DEA
Ohio Physicians Health Program – David G. Goldberg, D.O., Medical Director, Ohio Physicians Health Program
Inventories, Records, and Reports – Marsha L.D. Ikner, Staff Coordinator, Liaison Section, Diversion Control Division, DEA
Registration Issues – Loren T. Miller, Section Chief, Policy Section, Diversion Control Division, DEA
Disposal, Return of Patient Meds, and Options for Patients – Marsha L.D. Ikner, Staff Coordinator, Liaison Section, Diversion Control Division, DEA
Telemedicine – James A. Arnold, Section Chief, Liaison Section, Diversion Control Division, DEA
Training & Resources – Aziz Elkholy, Staff Coordinator, Liaison Section, Diversion Control Division, DEA
The Ohio Automated RX Reporting System (OARRS) – Jenni Wai, RPh, Chief Pharmacist, State of Ohio Board of Pharmacy